c

Lipid modification in GP (Nice update 2021)

11th October 2021 by Dr Louise Hudman

Lipid modification in GP (Nice update 2021)

NICE has recently released guidance on the use of bempedoic acid in lipid modification. This prompted me to look back at the guidance on lipid modification and I came across a useful document from NICE called a ‘Key Therapeutic Topic’.

They are not guidance per se, but outline different medication options and link into other NICE guidance, so they are quite useful. There are plenty of others too.

Given my knowledge of when to add in ezetimibe and the other medications was a bit hazy and given the new guidance on bempedoic acid, I thought it useful to do a bit of a summary on what we should use and when.

What different guidelines are available from NICE on lipid modification?

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

More cardiology guidelines

"The NASGP and the GP locum chambers that I'm in have provided invaluable assistance both before and through Covid-19 to me as a full-time GP locum. All aspects of locum work have been made easier as a result of membership and the chamber's support structure - from accessing work, to ensuring invoicing and documentation is all sorted, and access to other locums as peer support. Having a chamber manager means I feel more secure and can devote more of my energy on my clinical work."

Dr Richard Smith, GP, Suffolk

Dr Richard Smith, GP, Suffolk

See the full list of features within our NASGP membership plans

Membership